Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion type Assertion NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_head.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion description "[Investigational PI3K pathway inhibitors represent a promising new therapeutic strategy in uterine cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_provenance.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion evidence source_evidence_literature NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_provenance.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion SIO_000772 21903247 NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_provenance.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion wasDerivedFrom befree-20140225 NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_provenance.
- NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_assertion wasGeneratedBy ECO_0000203 NP523591.RA61tWxlfl2GsbhmwNsT7yQhqij-ujcEpWXRVnRP8LyPo130_provenance.